Dr. Dirk Westermann and Dr. Yazan Daaboul Discuss: Prediction of Preeclampsia Using High-Sensitivity Troponin I March 6, 2023 Disclosures: TBD
Dr. Suzanne Baron, Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: ACC 2023 ACCess Points Daily Wrap-up – March 5, 2023 March 5, 2023 Disclosures: TBD
Dr. Hyo-Soo Kim and Dr. C. Michael Gibson Discuss: Comparison of 3-month Versus 12-month Dual Antiplatelet Therapy After Coronary Intervention Using the Contemporary Drug-eluting Stents With Ultrathin Struts And Advanced Polymer Technology: The HOST-IDEA Randomized Clinical Trial March 5, 2023 Disclosures: TBD
Dr. Raj Makkar and Dr. C. Michael Gibson Discuss: Safety And Efficacy Of Transcatheter Edge-to-Edge Mitral Repair In Degenerative Mitral Regurgitation: An Analysis Of The STS/ACC TVT Registry March 5, 2023 Disclosures: TBD
Dr. Mitchell Silver, Dr. Jay Giri, and Dr. C. Michael Gibson Discuss: Outcomes in High-risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy: Results From The FLAME Study March 5, 2023 Disclosures: TBD
Dr. Iulia Iatan and Dr. C. Michael Gibson Discuss: Association of a Low-carbohydrate High-fat (Ketogenic) Diet With Plasma Lipid Levels and Cardiovascular Risk in a Population-based Cohort March 5, 2023 Disclosures: TBD
Dr. Barry Borlaug and Dr. C. Michael Gibson Discuss: RAPID-HF: Atrial Pacing For Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial March 5, 2023 Disclosures: TBD
Dr. John Forrest and Dr. C. Michael Gibson Discuss: Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients At Low Surgical Risk: 3-year Outcomes From The Evolut Low Risk Trial March 5, 2023 Disclosures: TBD
Dr. Roberto Diletti and Dr. C. Michael Gibson Discuss: BIOVASC: Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndromes and Multivessel Coronary Disease March 5, 2023 Disclosures: TBD
Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: Transcatheter Edge-to-edge Repair of Functional Mitral Regurgitation in Heart Failure: Final Five-year Results From the COAPT Trial March 5, 2023 Disclosures: TBD
